LXM.2

N/A

Report date: 2025/06/11 10:35:33

Base Information

Drug NameLXM.2
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsWeight LossObesityDiabetes Mellitus +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLaxxon Medical AG
China Registration ClassN/A

Develop Information

Active CompaniesLaxxon Medical AG
Inactive CompaniesN/A
Active IndicationsWeight LossObesityDiabetes Mellitus +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A